NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for ...

Time is running out for some Walgreens shoppers to file for their part of a proposed class action settlement that accuses the pharmacy chain of overcharging for generic drugs.

Mass General Brigham researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications, such as semaglutide or tir ...